Choong Ang Vaccine Laboratory Co., Ltd. Stock: price and insider trades · South Korea
중앙백신
No insider purchase over the last 90 days. The latest, by 신영학, was filed 06 Aug 2026.
Choong Ang Vaccine Laboratory Co., Ltd.: what insiders have been doing
Choong Ang Vaccine Laboratory Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). From 1 November 2025 to 1 November 2026, the disclosure feed for Choong Ang Vaccine Laboratory Co., Ltd. logged 6 filings by 5 insiders.
Not one open-market sale was filed. On the buying side, 4 insiders reported 5 purchases totalling €251k. The totals exclude 3 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 김은희 filed the largest purchase, €175k, on 29 April 2026, which represents 0.33% of the company's market value. On the buying side, the filings list 2 board members, 2 chief executives and 1 major shareholder among the declarants.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 6 filings, this issuer sits below that mark. Our records for Choong Ang Vaccine Laboratory Co., Ltd. go back to 2021, with 9 purchases and 5 sales on the open market in total.
Within a 30-day window, 1 purchase overlapped with buying by a second insider. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (6 August 2026) now reads 96 days.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -12.6%Entry ₩10,080 · Close 30 Oct 2026 ₩8,810
- -13.1%Entry ₩10,140 · Close 30 Oct 2026 ₩8,810
- -28.3%Entry ₩14,500 · Close at T+365 ₩10,400
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 2,195 sharesShareKRXDART:20260806000155Canonical exit: 4 Nov 2026 (T+90)
- 43,397 sharesKRXDART:20260615000118Canonical exit: 13 Sept 2026 (T+90)
- 11,000 sharesShareKRXDART:20260615000106Canonical exit: 13 Sept 2026 (T+90)
- 31,000 shares@ ₩9,794.5310.33% mcap100.0% of flowShareKRXDART:20260429000305Canonical exit: 26 Jul 2026 (T+90)
- 13,515 shares@ ₩9,671.99730.14% mcap100.0% of flowShareKRXDART:20260428000120Canonical exit: 23 Jul 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- 717,151 sharesShareKRXDART:20250108000168Canonical exit: 8 Apr 2025 (T+90)
- 2,565 sharesShareKRXDART:20241104000029
- 59,080 sharesKRXDART:20240724000382
- 59,080 sharesKRXDART:20230818000235
- ShareKRXDART:20230509000561
- 59,080 sharesKRXDART:20230407003156
- ●Executives0DART
- ShareKRXDART:20220506000536
- 48,944 sharesKRXDART:20220406002339
- 2,627 sharesShareKRXDART:20220405002782Canonical exit: 28 Jun 2022 (T+90)
- 3,707 sharesShareKRXDART:20220325000911Canonical exit: 19 Jun 2022 (T+90)
- 6,166 sharesShareKRXDART:20220317001137Canonical exit: 9 Jun 2022 (T+90)
- ●Executives0DART
- ●Executives0DART
- ShareKRXDART:20210513000601
- ●Executives0DART
23 of 23 declarations
About Choong Ang Vaccine Laboratory Co., Ltd.
Central Vaccine is a company operating in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development and distribution of vaccines.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
